Sunrest Lifescie
: SUNREST · Pharmaceuticals
Limited coverage
We are not actively covering this company or have limited coverage today. Click to request coverage.
Snapshot
Unlock Sunrest Lifescie's vital signs
Growth · Profitability · Valuation · Strength · Conviction
Company Overview
Business
Sunrest Lifescience Ltd is an Indian pharmaceutical company engaged in the wholesale and retail trading of healthcare and cosmetic products. Its diverse product portfolio includes capsules, tablets, syrups, ointments, gels, and various personal care items.
Business Model
The company operates as a trader of pharmaceutical and personal care products, sourcing and distributing OTC brands to meet market demand. It generates revenue through the sale of healthcare and cosmetic formulations across retail and wholesale channels.
Growth Outlook
Growth is expected to be driven by the expansion of its OTC healthcare and personal care product offerings. The company aims to leverage its distribution network to increase market penetration within the Indian pharmaceutical sector.
Key Risks
- Regulatory Compliance. The company is subject to stringent pharmaceutical regulations and licensing requirements that could impact operations if standards are not maintained.
- Supply Chain Dependency. As a trading entity, the company is vulnerable to disruptions in the supply chain or price volatility from its third-party manufacturers.
- Market Competition. The Indian pharmaceutical and OTC market is highly fragmented and competitive, which may exert pressure on profit margins.
Start your research today
Unlock AI insights, financials, peers and live data on Sunrest Lifescie and 5,000+ companies — free.
Peers · Pharmaceuticals
| Company | Mkt Cap | P/E | EV/EBITDA | Rev Gr YoY | EBITDA Mgn | ROE | ROCE | 1Y Return |
|---|---|---|---|---|---|---|---|---|
Sunrest LifescieSUNREST | ₹68 Cr | — | — | — | 14.5% | — | — | -19.5% |
Albert DavidALBERTDAVD | ₹513 Cr | 22.73 | 13.48 | 11.4% | 11.0% | 5.8% | 7.5% | +12.1% |
Jenburkt Pharmaceuticals LimitedJENBURPH | ₹463 Cr | 13.31 | 8.46 | — | 32.0% | 17.6% | 23.2% | -4.3% |
Haleos Labs LimitedHALEOSLABS | ₹452 Cr | 28.60 | 12.72 | -3.1% | 13.6% | 7.4% | 10.3% | — |
TranschemTRANSCHEM | ₹424 Cr | 98.76 | 68.07 | -100.0% | 177.7% | 5.3% | 7.0% | +592.6% |
Medicamen BiotecMEDICAMEQ | ₹338 Cr | 33.59 | 15.53 | 24.7% | 11.3% | 4.1% | 6.2% | -27.9% |
As of Mar 2026
Financials
Sunrest Lifescie
: SUNREST · Pharmaceuticals
Limited coverage
We are not actively covering this company or have limited coverage today. Click to request coverage.
Snapshot
Unlock Sunrest Lifescie's vital signs
Growth · Profitability · Valuation · Strength · Conviction
Company Overview
Business
Sunrest Lifescience Ltd is an Indian pharmaceutical company engaged in the wholesale and retail trading of healthcare and cosmetic products. Its diverse product portfolio includes capsules, tablets, syrups, ointments, gels, and various personal care items.
Business Model
The company operates as a trader of pharmaceutical and personal care products, sourcing and distributing OTC brands to meet market demand. It generates revenue through the sale of healthcare and cosmetic formulations across retail and wholesale channels.
Growth Outlook
Growth is expected to be driven by the expansion of its OTC healthcare and personal care product offerings. The company aims to leverage its distribution network to increase market penetration within the Indian pharmaceutical sector.
Key Risks
- Regulatory Compliance. The company is subject to stringent pharmaceutical regulations and licensing requirements that could impact operations if standards are not maintained.
- Supply Chain Dependency. As a trading entity, the company is vulnerable to disruptions in the supply chain or price volatility from its third-party manufacturers.
- Market Competition. The Indian pharmaceutical and OTC market is highly fragmented and competitive, which may exert pressure on profit margins.
Start your research today
Unlock AI insights, financials, peers and live data on Sunrest Lifescie and 5,000+ companies — free.
Peers · Pharmaceuticals
As of Mar 2026